These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20065253)

  • 1. B-cell activating factor of the TNF family is upregulated in neuromyelitis optica.
    Okada K; Matsushita T; Kira J; Tsuji S
    Neurology; 2010 Jan; 74(2):177-8. PubMed ID: 20065253
    [No Abstract]   [Full Text] [Related]  

  • 2. B-cell activating factor in the cerebrospinal fluid of neuromyelitis optica and multiple sclerosis.
    Zhang H
    Mult Scler; 2011 May; 17(5):639-40; author reply 641. PubMed ID: 21382861
    [No Abstract]   [Full Text] [Related]  

  • 3. Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis.
    Piazza F; DiFrancesco JC; Fusco ML; Corti D; Pirovano L; Frigeni B; Mattavelli L; Andreoni S; Frigo M; Ferrarese C; Tredici G; Cavaletti G
    J Neuroimmunol; 2010 Mar; 220(1-2):104-7. PubMed ID: 20149932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated B-cell activating factor BAFF, but not APRIL, correlates with CSF cerebellar autoantibodies in pediatric opsoclonus-myoclonus syndrome.
    Fühlhuber V; Bick S; Kirsten A; Hahn A; Gerriets T; Tschernatsch M; Kaps M; Preissner KT; Blaes F; Altenkämper S
    J Neuroimmunol; 2009 May; 210(1-2):87-91. PubMed ID: 19339060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potential role for B-cell activating factor in the pathogenesis of autoimmune myasthenia gravis.
    Ragheb S; Lisak R; Lewis R; Van Stavern G; Gonzales F; Simon K
    Arch Neurol; 2008 Oct; 65(10):1358-62. PubMed ID: 18852352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders.
    Banwell B; Tenembaum S; Lennon VA; Ursell E; Kennedy J; Bar-Or A; Weinshenker BG; Lucchinetti CF; Pittock SJ
    Neurology; 2008 Jan; 70(5):344-52. PubMed ID: 18094334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMO-IgG in the diagnosis of neuromyelitis optica.
    Jarius S; Franciotta D; Bergamaschi R; Wright H; Littleton E; Palace J; Hohlfeld R; Vincent A
    Neurology; 2007 Mar; 68(13):1076-7. PubMed ID: 17287449
    [No Abstract]   [Full Text] [Related]  

  • 8. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
    Hinson SR; McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Pittock SJ
    Arch Neurol; 2009 Sep; 66(9):1164-7. PubMed ID: 19752309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Finding NMO: neuromyelitis optica in children.
    Levy M; Birnbaum J; Kerr D
    Neurology; 2008 Jan; 70(5):334-5. PubMed ID: 18227415
    [No Abstract]   [Full Text] [Related]  

  • 10. Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica.
    McKeon A; Lennon VA; Jacob A; Matiello M; Lucchinetti CF; Kale N; Chan KH; Weinshenker BG; Apiwattinakul M; Wingerchuk DM; Pittock SJ
    Muscle Nerve; 2009 Jan; 39(1):87-90. PubMed ID: 19086079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic cellular immunity and neuroinflammation during acute flare-up in multiple sclerosis and neuromyelitis optica spectrum disorder patients.
    Uchida N; Mori K; Fujita-Nakata M; Nakanishi M; Sanada M; Nagayama S; Sugiyama H; Matsui M
    J Neuroimmunol; 2021 Apr; 353():577500. PubMed ID: 33592574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of humoral immunity and eosinophils in neuromyelitis optica.
    Correale J; Fiol M
    Neurology; 2004 Dec; 63(12):2363-70. PubMed ID: 15623701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid levels of CXCL13 are elevated in neuromyelitis optica.
    Zhong X; Wang H; Dai Y; Wu A; Bao J; Xu W; Cheng C; Lu Z; Qiu W; Hu X
    J Neuroimmunol; 2011 Dec; 240-241():104-8. PubMed ID: 22036953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay.
    Hayakawa S; Mori M; Okuta A; Kamegawa A; Fujiyoshi Y; Yoshiyama Y; Mitsuoka K; Ishibashi K; Sasaki S; Hattori T; Kuwabara S
    J Neuroimmunol; 2008 May; 196(1-2):181-7. PubMed ID: 18462810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of CNS demyelinating disease in patients with myasthenia gravis.
    Weinshenker BG; Jacob A
    Neurology; 2007 Apr; 68(16):1326; author reply 1327. PubMed ID: 17438233
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum concentration of CD40L is elevated in inflammatory demyelinating diseases.
    Zhong X; Wang H; Ye Z; Qiu W; Lu Z; Li R; Shu Y; Chang Y; Hu X
    J Neuroimmunol; 2016 Oct; 299():66-69. PubMed ID: 27725124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic criteria in acute neuromyelitis].
    Panea C; Petrescu S; Monica P; Voinea L; Dascălu AM; Nicolae M; Ungureanu E; Panca A; Grădinaru S
    Oftalmologia; 2007; 51(4):116-20. PubMed ID: 18543687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of remitting neuromyelitis optica spectrum disorders from multiple sclerosis by integrating parameters from serum proteins and lymphocyte subsets.
    Ip PP; Chung CY; Chang CC; Lee YF; Wang HM; Lian IB; Fann CS; Yang CC; Liao F
    J Neuroimmunol; 2018 May; 318():45-52. PubMed ID: 29455925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromyelitis optica.
    Feingold RM
    J Insur Med; 2008; 40(2):136-40. PubMed ID: 19119594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding the spectrum of neuromyelitis optica: friend or foe?
    Behbehani R
    Curr Opin Ophthalmol; 2007 Nov; 18(6):459-62. PubMed ID: 18162996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.